Stocks declined Tuesday as investors digested weaker-than-expected export data from China and the potential for more U.S. bank debt downgrades.
These stocks made moves on Tuesday:
Eli Lilly
(ticker: LLY) rose 15% after the pharmaceutical giant smashed second-quarter earnings and sales expectations and said it expects adjusted earnings in 2023 of $9.70 to $9.90 a share, up from a prior forecast of $8.65 to $8.85. The company closed with a market cap of $495 billion, according to Dow Jones Market Data.
Read the full article here
